RPG Investment Advisory’s Edwards Lifesciences EW Stock Holding History

RPG Investment Advisory’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-90	Closed	-$8K	–	354
2021 Q1	$8K	Hold	90	–	–	﹤0.01%	239
2020 Q4	$8K	Hold	90	–	–	﹤0.01%	215
2020 Q3	$7K	Hold	90	–	–	﹤0.01%	210
2020 Q2	$6K	Hold	90	–	–	﹤0.01%	225
2020 Q1	$6K	Sell	90 -15	-14%	-$1.08K	﹤0.01%	193
2019 Q4	$8K	Sell	105 -15	-13%	-$1.17K	﹤0.01%	190
2019 Q3	$9K	Hold	120	–	–	﹤0.01%	178
2019 Q2	$7K	Hold	120	–	–	﹤0.01%	193
2019 Q1	$8K	Hold	120	–	–	﹤0.01%	207
2018 Q4	$6K	Hold	120	–	–	﹤0.01%	215
2018 Q3	$7K	Hold	120	–	–	﹤0.01%	234
2018 Q2	$6K	Buy	+120	New	+$5.6K	﹤0.01%	245
2017 Q4	–	Sell	-120	Closed	-$4K	–	490
2017 Q3	$4K	Hold	120	–	–	﹤0.01%	295
2017 Q2	$5K	Buy	+120	New	+$4.38K	﹤0.01%	244

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

RPG Investment Advisory's EW Position: Q2 2021 in Review

RPG Investment Advisory sold out of Edwards Lifesciences (EW) in Q2 2021, closing a stake of 90 shares — an estimated $8K sold.

RPG Investment Advisory first reported a position in EW in Q2 2017 and held it in 14 quarters. The position peaked at $9K in Q3 2019. 1,188 funds tracked by Wall St. Rank hold EW as of Q2 2021.

RPG Investment Advisory reported no remaining Edwards Lifesciences position as of Q2 2021 after selling out during the quarter.
RPG Investment Advisory sold 90 Edwards Lifesciences shares in Q2 2021, an estimated $8K.
RPG Investment Advisory first reported a position in Edwards Lifesciences in Q2 2017 and held it in 14 quarters.
RPG Investment Advisory's Edwards Lifesciences position peaked at $9K in Q3 2019.
1,188 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on RPG Investment Advisory's 13F filing for Q2 2021, filed 3 Aug 2021.